Has Omar Alsharif received payments from drug or device companies?

Yes. Drug and device makers reported $5,645 in general payments to Omar Alsharif across 247 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Omar Alsharif did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Omar Alsharif come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Omar Alsharif

Hospitalist · Knoxville, TNNPI 1548758527

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,913 of the $5,645 with a category attached, or 87.0%. It is spread thinly across 54 manufacturers, the largest accounting for just 9.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,555, more than ten times the $17 reported in 2019. Among hospitalist clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,645in general payments, 2019–2025

Across 247 payments — averaging $22.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Astellas Pharma US Inc$546
Merck$404
Johnson & Johnson$399
E.r. Squibb & Sons, L.L.C.$318
Novartis$311
Incyte Corporation$280
plus $3K from 48 others

What the payments were for

Food & beverage$4,91387%
Education$73213%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Astellas Pharma US Inc	11	$546
Merck	17	$404
Johnson & Johnson(2 entities)	20	$399
E.r. Squibb & Sons, L.L.C.	24	$318
Novartis	13	$311
Incyte Corporation	11	$280
Pfizer	10	$265
Genentech USA, Inc.	11	$214
AbbVie	4	$206
Takeda Pharmaceuticals U.S.A., Inc.	8	$174
AVEO Pharmaceuticals, Inc.	5	$158
Regeneron Healthcare Solutions, Inc.	6	$154
Sanofi	6	$153
EMD Serono, Inc.	7	$142
AstraZeneca(2 entities)	7	$138
Bristol Myers Squibb	7	$138
Exelixis Inc.	5	$111
Lilly USA, LLC	5	$95
Deciphera Pharmaceuticals Inc.	5	$94
Rigel Pharmaceuticals, Inc.	5	$93
Gilead(2 entities)	4	$85
Bayer	4	$76
Eisai Inc.	3	$74
Immunocore Limited	3	$72
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	4	$62
Blueprint Medicines Corporation	3	$57
Caris MPI, Inc.	3	$56
Intuitive Surgical	1	$52
Seagen Inc.	2	$50
Daiichi Sankyo Inc.	2	$48
Geron Corporation	2	$46
Genmab U.S., Inc.	2	$46
Karyopharm Therapeutics Inc.	2	$46
Puma Biotechnology, Inc.	2	$30
Pharmacosmos Therapeutics Inc.	2	$29
Myriad Genetic Laboratories, Inc.	2	$29
Mallinckrodt Hospital Products Inc.	1	$29
Amgen	2	$28
Mirati Therapeutics, Inc.	1	$27
Acrotech Biopharma Inc.	1	$27
Kyowa Kirin, Inc.	1	$26
Sobi, Inc	1	$25
Beigene USA, Inc.	1	$23
Abiomed	1	$23
Jazz Pharmaceuticals Inc.	1	$22
Boehringer Ingelheim	1	$22
Sun Pharmaceutical Industries Inc.	1	$20
Tempus AI, Inc	1	$20
Cumberland Pharmaceuticals, Inc.	1	$19
Pharming Healthcare, Inc.	1	$18
Alkermes, Inc.	1	$18
Mylan Specialty L.p.	1	$17
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$15
Adaptive Biotechnologies Corporation	1	$14

How this compares

$5,645 in reported general payments places this provider in the 95th percentile of 349 hospitalist providers in Tennessee.

See all hospitalist providers in Tennessee →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Letrozole	11	$265

Paid to pharmacies, not to this prescriber.

Other hospitalist in Knoxville

Lindsay Rumberger-RiveraKnoxville$4K
Nathan SmithKnoxville$4K
Julia van ZylKnoxville$2K
Landy MoralesKnoxville$1K
Flavius DragilaKnoxville$1K
Clayton HumphreyKnoxville$1K
Issam AlmashharawiKnoxville$1K
Jano JanoyanKnoxville$1K
Sahar LotfiKnoxville$1K
Reem HusseinKnoxville$1K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →